The contribution of AT1 and AT2 angiotensin receptors to its cognitive effects

Acta Neurobiologiae Experimentalis

Volumn 56, Issue 1, 1996, Pages 49-54

  Braszko, Jan ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

angiotensin receptor subtypes; angiotensins; memory; motor behaviour; rat

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; APOMORPHINE; LOSARTAN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; ANTIHYPERTENSIVE AGENT; BIPHENYL DERIVATIVE; IMIDAZOLE DERIVATIVE; OLIGOPEPTIDE; TETRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; LOCOMOTION; MEMORY; NONHUMAN; RAT; ANIMAL; ARTICLE; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; COGNITION; IMIDAZOLES; LOSARTAN; OLIGOPEPTIDES; RATS; RECEPTORS, ANGIOTENSIN; TETRAZOLES;

EID: 0029868056     PISSN: 00651400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (43)

1. Ader R., Weijnen J. A. W.M., Moleman P. (1971) Retention of a passive avoidance response as a function of the intensity and duration of electric shock. Psychon. Sci. 26: 125-129.
2. Banks R.J.A., Dourish C.T. (1991) The angiotensin receptor antagonists DuP 753 and WL 19 block apomorphine-induced stereotypy in the rat. Br. J. Pharmacol. 104 (Oct. Suppl.): 63.
3. Baranowska D., Braszko J.J., Wiśniewski K. (1983) Effect of angiotensin II and vasopressin on acquisition and extinction of conditioned avoidance in rats. Psychopharmacology 81: 247-251.
4. Braszko J.J., Holy Z., Kupryszewski G., Witczuk B. (1991) Effect of angiotensin II, its 2-8,3-8,4-8 fragments and saralasin on the level and turnover of dopamine in the striatum and olfactory tubercle of the rat. Asia. Pac. J. Pharmacol. 6: 243-247.
5. Braszko J.J., Kułakowska A., Karwowska W., Wiśniewski K. (1994) Effect of losartan on the memory enhancing activity of angiotensin II and angiotensin II (3-7). Pol. J. Pharmacol. 46: 263-264.
6. Braszko J.J., Kułakowska A., Wiśniewski K. (1995) Angiotensin II and its 3-7 fragment improve recognition but not spatial memory in rats. Brain Res. Bull. 37: 627-631.
7. Braszko J.J., Kupryszewski G., Witczuk B., Winiewski K. (1988) Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats. Neuroscience 27: 777-783.
8. Braszko J., Rogowski F., Wiśniewski K. (1986) Prostaglandins mediate some central effects of angiotensin II. Pol. J.Pharmacol. Pharm. 38: 349-358.
9. Braszko J., Wiśniewski K. (1976) Effect of angiotensin on the central action of dopamine. Pol. J.Pharmacol. Pharm. 28: 667-672.
10. Braszko J.J., Wiśniewski K. (1988) Effect of angiotensin II and saralasin on motor activity and passive avoidance behaviour of rats. Peptides 9: 475-479.
11. Braszko J.J., Wiśniewski K. (1990) Alpha 1 and alpha 2 adrenergic receptor blockade influences angiotensin II facilitation of avoidance behaviour and stereotypy in rats. Psychoneuroendocrinology 15: 239-252.
12. Braszko J.J., Wiśniewski K., Kupryszewski G., Witczuk B. (1987) Psychotropic effects of angiotensin II and III in rats: locomotor and exploratory vs cognitive behaviour. Behav. Brain Res. 25: 195-203.
13. Braszko J.J., Własienko J., Koziołkiewicz W., Janecka A., Wiśniewski K. (1991) The 3-7 fragment of angiotensin II is probably responsible for its psychoactive properties. Brain Res. 542: 49-54.
14. Bushnell P.J., Levin E.D. (1993) Effects of dopaminergic drugs on working and reference memory in rats. Pharmacol. Biochem. Behav. 45: 765-776.
15. Cavoy A., Delacour J. (1993) Spatial but not object recognition is impaired by ageing in rats. Psych. Behav. 53: 527-530.
16. Chiu A. T., Herblin W. F., McCall D.E., Ardecky R.J., Carini D.J., Duncia J.V., Pease Wang P.C., Wexler R.R., Johnson A.L., Timmermans P.B.M.W.M. (1989) Identification of angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 165: 196-203.
17. 3 receptors of rat and guinea pig brain. Eur. J. Pharm. 256:73-78.
18. Decker M.W., McGaugh J.L. (1991) The role of interactions between the cholinergic system and other neuromodulatory systems in learning and memory. Synapse 7: 151-168.
19. Dwoskin L.P., Jewell A.L., Cassis L.A. (1992) DuP 753, a nonpeptide angiotensin II-1 receptor antagonist, alters dopaminergic function in rat striatum. Naunyn-Schmiedeberg's Arch. Pharmacol. 345: 153-159.
20. Ernst A.M., Smelik P.G. (1966) Site of action of dopamine and apomorphine on gnawing behaviour in rats. Experientia 22: 837-838.
21. Hoły Z., Braszko J. J., Kupryszewski G., Witczuk B., Wiśniewski K. (1992) Angiotensin II - derived peptides devoid of phenylalanine in position 8 have full psychotropic activity of the parent hormone. J. Physiol. Pharmacol. 43: 183-192.
22. Hoły Z., Braszko J.J., Wiśniewski K. (1993) Psychotropic effects of angiotensin II N-terminal fragments Asp-Arg-Val-Tyr-Ile-His and Arg-Val-Tyr-Ile-His in rats. Pol. J. Pharmacol. 45: 31-41
23. Kaiser F.C., Palmer G.G., Wallace A.V., Carr R.D., Fraser-Rack L., Hallam C. (1992) Antianxiety properties of the angiotensin II antagonist, DuP 753, in the rat using the elevated plus-maze. NeuroReport 3: 922-924.
24. 1 receptor inhibitor, on the behavioural effects of angiotensin II (3-7). Doctoral dissertation. Medical Academy of Białystok.
25. Kovacs G.L., De Wied D. (1994) Peptidergic modulation of learning and memory processes. Pharmacol. Rev. 46:269-291.
26. 1 receptor inhibitor, on the behavioural effects of angiotensin II. Doctoral dissertation. Medical Academy of Biłaystok.
27. Laufer R.C., Wormser U., Friedman Z.Y., Gilon C., Chorev M., Salinger Z. (1985) Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonised by enkephalin. Proc. Natl. Acad. Sci. USA 82: 7444-7448.
28. Mann J.F.E., Shiller P.W., Schriftrin E.L., Boncker R., Genest J. (1981). Brain receptor binding and central actions of angiotensin analogs in rats. Am. J. Physiol. 241: R124-R129
29. McGurk S.R., Levin E.D., Butcher L.L. (1992) Dopaminergic drugs reverse the impairment of radial-arm maze performance caused by the lesions involving the cholinergic medial pathway. Neuroscience 50: 129-135.
30. Packard M.G., White N.M. (1989) Memory facilitation produced by dopamine agonists: Role of receptor subtype and mnemonic requirements (1989). Pharmacol. Biochem. Behav. 33:511-518.
31. Packard M.G., White N.M. (1991) Dissociation of hippocampus and caudate nucleus memory systems by posttraining intracerebral injection of dopamine agonists. Behav. Neurosci. 105: 295-306.
32. Pellow S., File S.E. (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus - maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24: 525-529.
33. 1 dopamine receptors in prefrontal cortex: Involvement in working memory. Science 251: 947-950.
34. Simon H., Scatton B., Le Moal M. (1980) Dopaminergic A10 neurones are involved in cognitive functions. Nature 286: 150-151.
35. Simonnet G., Giorguieff-Chesselet M.F., Carayon A., Bioulac B., Cesselin P., Glowinski J., Vincent J.D. (1981) Angiotensin II et systeme nigro-neostriatal. J. Physiol. (Paris) 77: 71-79.
36. Stephenson K.N., Steele M.K. (1992) Brain angiotensin II receptor subtypes in the prolactin secretion in female rats. J.Neuroendocrinol. 4:441-447.
37. 2 receptor ligands modulate the upper limit of cerebral blood flow autoregulation in rats. J. Cereb. Blood Flow Metab. 13: 298-303.
38. Sumners C., Philips M.I. (1983) Central injection of angiotensin II alters catecholamine activity in rat brain. Am. J. Physiol. 244: R257-R263.
39. Whitebread S., Mele M., Kamber B., de Gasparo M. (1989) Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem. Biophys. Res. Commun. 163: 284-291.
40. Wiśniewski K., Braszko J.J. (1984) The significance of central monoamine systems in the angiotensin II (A II) improvement of learning. Clin. Exper. Hypertens. Theory. Practice A6: 2127-2131.
41. Wiśniewski K., Braszko J.J. (1985) Some aspects of modulatory action of peptides in CNS. Beitr. Wirkstofforsch. 24: 113-124.
42. 2 . Biomed. Biochim. Acta 48: 707-713.
43. Wright J.W., Krebs L.T., Stobb J.W., Harding J.W. (1995) The angiotensin IV system: Functional implications. Frontiers Neuroendocrinol. 16: 23-52.